Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
Go back to Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting| (NASDAQ: LEGN) | Delayed: 17.61 +0.03 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.58 | 52 Week High | $ | |||
| Open | $17.71 | 52 Week Low | $ | |||
| Day High | $17.88 | P/E | N/A | |||
| Day Low | $17.22 | EPS | $ | |||
| Volume | 2,937,701 | |||||
